SCIENTIFIC HUB

Follow the evidence.

SCIENTIFIC LITERATURE · MED

Constipation and risk of cognitive impairment and dementia in adults: a systematic review and meta-analysis.

Front Neurol · 2025-06-04

DOI: 10.3389/fneur.2025.1600952PMID: 40534737

Open accessSystematic Review; systematic-review; Journal ArticleOriginal source ↗

Research overview

The text below is the source article’s original abstract under a verified reuse license. cc by

IntroductionIt has been shown that constipation may have a close association with the occurrence of cognitive impairment (CI). This study was aimed at assessing the risk of CI in patients with constipation and exploring the interactions of constipation with other factors affecting CI.MethodsEmbase, PubMed, Web of Science, and Cochrane were systematically searched to collect relevant literature for assessment of the association between constipation and CI. The included studies was subjected to quality assessment using the NIH quality assessment tool for observational cohort and cross-sectional studies. An odds ratio (OR) was calculated using a random effects model, and subgroup and sensitivity analyses were performed. Publication bias was assessed by the Egger's test and funnel plot, with a P-value of ResultsA total of 11 studies were included, including five retrospective studies and six cross-sectional studies, with 66,609 participants involved. The OR between constipation and cognitive impairment was 1.11 (95% CI: 1.03-1.20). Subgroup analysis showed that the OR between constipation and CI was 1.33 (95% CI: 1.12-1.58) in patients with Parkinson's disease and 1.05 (95% CI: 0.98-1.13) in patients without Parkinson's disease. The OR was 1.37 (95% CI: 1.07-1.74) in retrospective studies and 1.06 (95% CI: 0.98-1.15) in cross-sectional studies. The OR was 1.29 (95% CI: 0.92-1.80) in Europe and 1.12 (95% CI: 1.04-1.22) in Asia.ConclusionThe risk of CI was 1.11 times higher in constipated patients than in non-constipated patients. Constipation might significantly increase the risk of CI, especially in patients with Parkinson's disease.Systematic review registrationhttps://www.crd.york.ac.uk/PROSPERO/view/CRD42025630902, identifier: CRD42025630902.

Scientific assessment

01

Research question

Assess the question within the original study’s scope.

02

Methods & sample

Check the source article for study design and sample details.

03

Key findings

An editorially approved findings summary is not yet published for this record.

04

Limitations

Generalizability, bias and clinical meaning require separate assessment.

Methods, samples and clinical conclusions are not inferred from bibliographic metadata.